Cargando…
Berberine Could Ameliorate Cardiac Dysfunction via Interfering Myocardial Lipidomic Profiles in the Rat Model of Diabetic Cardiomyopathy
Background: Diabetic cardiomyopathy (DCM) is considered to be a distinct clinical entity independent of concomitant macro- and microvascular disorders, which is initiated partly by disturbances in energy substrates. This study was to observe the dynamic modulations of berberine in DCM rats and explo...
Autores principales: | Dong, Shifen, Zhang, Shuofeng, Chen, Zhirong, Zhang, Rong, Tian, Linyue, Cheng, Long, Shang, Fei, Sun, Jianning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6090155/ https://www.ncbi.nlm.nih.gov/pubmed/30131709 http://dx.doi.org/10.3389/fphys.2018.01042 |
Ejemplares similares
-
Changes of myocardial lipidomics profiling in a rat model of diabetic cardiomyopathy using UPLC/Q-TOF/MS analysis
por: Dong, Shifen, et al.
Publicado: (2017) -
Metabonomic Characteristics of Myocardial Diastolic Dysfunction in Type 2 Diabetic Cardiomyopathy Patients
por: Hao, Mingyu, et al.
Publicado: (2022) -
Metformin Ameliorates Diabetic Cardiomyopathy by Activating the PK2/PKR Pathway
por: Yang, Zhen, et al.
Publicado: (2020) -
Lipidomics Revealed Alteration of Sphingolipid Metabolism During the Reparative Phase After Myocardial Infarction Injury
por: Hua, Tong, et al.
Publicado: (2021) -
Myocardial Energy Metabolism in Non-ischemic Cardiomyopathy
por: Greenwell, Amanda A., et al.
Publicado: (2020)